Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
81.41B | 91.99B | 88.23B | 69.98B | 59.54B | Gross Profit |
11.30B | 12.03B | 15.74B | 18.10B | 17.10B | EBIT |
5.59B | 5.08B | 13.07B | 15.56B | 14.12B | EBITDA |
8.50B | 10.71B | 14.84B | 17.65B | 15.88B | Net Income Common Stockholders |
3.18B | 4.29B | 7.66B | 10.48B | 9.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.12B | 10.54B | 10.12B | 8.98B | 7.12B | Total Assets |
148.70B | 157.29B | 163.15B | 140.72B | 112.07B | Total Debt |
59.24B | 61.39B | 57.70B | 50.70B | 39.92B | Net Debt |
51.14B | 50.95B | 47.69B | 42.41B | 32.80B | Total Liabilities |
87.95B | 92.50B | 91.08B | 80.86B | 66.28B | Stockholders Equity |
53.93B | 57.90B | 63.58B | 51.94B | 39.60B |
Cash Flow | Free Cash Flow | |||
5.28B | 4.07B | 867.30M | -71.24M | -640.85M | Operating Cash Flow |
11.34B | 10.03B | 9.88B | 8.28B | 6.49B | Investing Cash Flow |
-7.05B | -7.51B | -12.21B | -8.32B | -9.45B | Financing Cash Flow |
-5.86B | -1.41B | 3.69B | 865.58M | -2.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $7.01B | 12.85 | 12.22% | 4.60% | -14.01% | ― | |
75 Outperform | $4.49B | 18.67 | 7.76% | 4.00% | -3.96% | 11.40% | |
75 Outperform | $4.66B | 20.09 | 7.59% | 3.40% | -12.16% | -5.73% | |
73 Outperform | $4.85B | 11.99 | 5.56% | 6.66% | -5.19% | 9.01% | |
71 Outperform | $4.93B | 14.80 | 15.15% | 3.60% | 9.18% | 36.67% | |
70 Outperform | $5.21B | 26.53 | 5.84% | 3.42% | -5.92% | 29.47% | |
63 Neutral | $8.54B | 12.50 | 6.24% | 4.37% | 2.99% | -10.18% |